On May 24, 2021, the Company registered the CARDIOVICE products™ to the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. This means that starting from 7 June this year, the Company may market its products.
The following products were registered:
- ECG signal recorder – CARDIOVICE ECG Recorder
- Mobile applictaion – CARDIOVICE App (iOS, Android)
- ECG vest – CARDIOVICE ECG Vest
- ECG module – CARDIOVICE ECG Module